About: Laragh John H.

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Laragh John H. Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	Person
name	Laragh John H. Laragh J.H. Laragh John
familyName	Laragh
Given name	J.H. John John H.
is relates of	http://hub.abes.fr/oup/periodical/ajh/2006/volume_19/issue_12/101016jamjhyper200610004/authorship/1 http://hub.abes.fr/oup/periodical/ajh/2003/volume_16/issue_s1/101016s0895706103001134/authorship/7 http://hub.abes.fr/oup/periodical/ajh/2004/volume_17/issue_s1/101016jamjhyper200403416/authorship/4 http://hub.abes.fr/oup/periodical/ajh/2000/volume_13/issue_s2/101016s0895706100004453/authorship/6 http://hub.abes.fr/oup/periodical/ajh/2001/volume_14/issue_11/101016s0895706101022452/authorship/2 http://hub.abes.fr/oup/periodical/ajh/2005/volume_18/issue_s4/101016jamjhyper200503178/authorship/3 http://hub.abes.fr/oup/periodical/ajh/2009/volume_22/issue_7/101038ajh200963/authorship/11 http://hub.abes.fr/oup/periodical/ajh/2009/volume_22/issue_9/101038ajh2009123/authorship/2 http://hub.abes.fr/oup/periodical/ajh/2004/volume_17/issue_3/101016jamjhyper200312003/authorship/4 http://hub.abes.fr/oup/periodical/ajh/2005/volume_18/issue_s4/101016jamjhyper200503003/authorship/3 http://hub.abes.fr/oup/periodical/ajh/2002/volume_15/issue_s3/101016s0895706102025761/authorship/8 http://hub.abes.fr/oup/periodical/ajh/2004/volume_17/issue_11/101016jamjhyper200408023/authorship/3 http://hub.abes.fr/oup/periodical/ajh/2009/volume_22/issue_1/101038ajh2008275/authorship/2 http://hub.abes.fr/oup/periodical/ajh/2005/volume_18/issue_9/101016jamjhyper200506004/authorship/1 http://hub.abes.fr/oup/periodical/ajh/2001/volume_14/issue_1/101016s0895706100013017/authorship/1 http://hub.abes.fr/oup/periodical/ajh/2001/volume_14/issue_4/101016s0895706101012821/authorship/1 http://hub.abes.fr/oup/periodical/ajh/2001/volume_14/issue_12/101016s0895706101022610/authorship/1 http://hub.abes.fr/oup/periodical/ajh/2001/volume_14/issue_3/101016s0895706101012808/authorship/1 http://hub.abes.fr/oup/periodical/ajh/2007/volume_20/issue_8/101016jamjhyper200704009/authorship/3 http://hub.abes.fr/oup/periodical/ajh/2001/volume_14/issue_9/101016s0895706101022221/authorship/1 http://hub.abes.fr/oup/periodical/ajh/2003/volume_16/issue_7/101016s089570610300904x/authorship/7 http://hub.abes.fr/oup/periodical/ajh/2004/volume_17/issue_11/101016jamjhyper200406017/authorship/6 http://hub.abes.fr/oup/periodical/ajh/2005/volume_18/issue_7/101016jamjhyper200506003/authorship/6 http://hub.abes.fr/oup/periodical/ajh/2002/volume_15/issue_12/101016s0895706102030613/authorship/4 http://hub.abes.fr/oup/periodical/ajh/2003/volume_16/issue_8/101016s0895706103008999/authorship/6 http://hub.abes.fr/oup/periodical/ajh/2000/volume_13/issue_8/101016s0895706100002776/authorship/7 http://hub.abes.fr/oup/periodical/ajh/2001/volume_14/issue_2/101016s0895706100013170/authorship/1 http://hub.abes.fr/oup/periodical/ajh/2001/volume_14/issue_5/101016s0895706101020490/authorship/1 http://hub.abes.fr/oup/periodical/ajh/2004/volume_17/issue_1/101016jamjhyper200308015/authorship/4 http://hub.abes.fr/oup/periodical/ajh/2010/volume_23/issue_9/101038ajh2010114/authorship/4 http://hub.abes.fr/oup/periodical/ajh/2002/volume_15/issue_10/101016s0895706102030017/authorship/4 http://hub.abes.fr/oup/periodical/ajh/2001/volume_14/issue_1/101016s089570610101281x/authorship/1 http://hub.abes.fr/oup/periodical/ajh/2001/volume_14/issue_8/101016s0895706101021951/authorship/1 http://hub.abes.fr/oup/periodical/ajh/2001/volume_14/issue_s1/101016s0895706101016259/authorship/7 http://hub.abes.fr/oup/periodical/ajh/2001/volume_14/issue_6/101016s0895706101020970/authorship/1 http://hub.abes.fr/oup/periodical/ajh/2001/volume_14/issue_7/101016s0895706101021562/authorship/1 http://hub.abes.fr/oup/periodical/ajh/2003/volume_16/issue_5/101016s0895706103008677/authorship/1 http://hub.abes.fr/oup/periodical/ajh/2004/volume_17/issue_5/101016jamjhyper200401003/authorship/7 http://hub.abes.fr/oup/periodical/ajh/2007/volume_20/issue_5/101016jamjhyper200704001/authorship/2
is Author of	Dr. Michael H. Alderman Takes the Helm as Editor-in-Chief of the American Journal of Hypertension OR-29: The value trial P-341: Ionic aspects of acute angiotensin receptor blockade in normal subjects Management of hypertensive crises: The scientific basis for treatment decisions Laragh's lessons in pathophysiology and clinical pearls for treating hypertension Beyond hypertension Laragh's lessons in pathophysiology and clinical pearls for treating hypertension Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the Renin-Aldosterone system OR-3: Plasma renin activity predicts myocardial infarction/revascularization among hypertensive patients P-160: Effects of olmesartan medoxomil (OLM) and valsartan (VAL) on the renin-angiotensin-aldosterone system (RAAS) in healthy normal subjects Laragh's lessons in pathophysiology and clinical pearls for treating hypertension Using Plasma Renin (PRA) Testing to Design Follow-Up Drug Treatment Strategies in Hypertensive Patients Already Taking Antirenin System Drugs Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT Plagiarism and scientific misconduct VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk Plasma Renin Test-Guided Drug Treatment Algorithm for Correcting Patients With Treated but Uncontrolled Hypertension: A Randomized Controlled Trial Abstract, closing summary, and table of contents for Laragh's 25 lessons in pathophysiology and 12 clinical pearls for treating hypertension Laragh's lessons in pathophysiology and clinical pearls for treating hypertension P-453 *Program Revision (see p. 267A): Gender specific characteristics of 15,288 hypertensive patients at high coronary risk. The value trial Hypertension guidelines: criteria that might make them more clinically useful: In reply: Plasma Renin Activity Levels in Hypertensive Persons: Their Wide Range and Lack of Suppression in Diabetic and in Most Elderly Patients B017: The valsartan antihypertensive longterm use evaluation (VALUE) trial: Final patients demographics Laragh's lessons in pathophysiology and clinical pearls for treating hypertension P-225: Predictors of one year blood pressure control and treatment resistance in the value trial The American Journal of Hypertension Withdraws from Its Affiliation with the American Society of Hypertension. A Report to Our Readers Pressor Responses to Antihypertensive Drug Types Laragh's lessons in pathophysiology and clinical pearls for treating hypertension Aliskiren Fails to Lower Blood Pressure in Patients Who Have Either Low PRA Levels or Whose PRA Falls Insufficiently or Reactively Rises Laragh's lessons in pathophysiology and clinical pearls for treating hypertension Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape Some Modifications at the Top Aliskiren, the First Renin Inhibitor for Treating Hypertension: Reactive Renin Secretion May Limit Its Effectiveness Plasma renin activity in the emergency department and its independent association with acute myocardial infarction Hypertension guidelines: criteria that might make them more clinically useful Clinical pearl #1: diuretic- induced-K+ depletion may be hazardous: the “miracle” of low-dose spironolactone Laragh's lessons in pathophysiology and clinical pearls for treating hypertension Left ventricular mass change during treatment and outcome in patients with essential hypertension Laragh's lessons in pathophysiology and clinical pearls for treating hypertension Effects of Angiotensin Receptor Blockers on Ambulatory Plasma Renin Activity in Healthy, Normal Subjects During Unrestricted Sodium Intake

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata